Search Tag: nirmatrelvir

2024 09 Jun

  In a recent clinical trial, a 15-day course of nirmatrelvir-ritonavir targeting SARS-CoV-2 was found to be safe as an extended-duration treatment. However, it did not alleviate specific symptoms of long COVID. These findings are published in JAMA Internal Medicine.   The combination of nirmatrelvir-ritonavir is approved by the FDA for treating...Read more